Rhythm Pharmaceuticals is a US commercial-stage biopharmaceutical company focused on MC4R pathway and committed to transforming the care for patients living with rare genetic diseases of obesity. Setmelanotide is the first and only FDA-approved and EC-authorised therapy that targets a root cause of hyperphagia and early-onset, severe obesity.My role is to work cross functionally and across countries (EMEA, LATAM, JAPAC) to drive strategic geographic expansion and overall growth through large-scale genetic diagnosis implementation.Geographic expansion: Drive successful execution of the international business plan by working closely with cross functional teams to evaluate opportunities, prioritise, and craft a path forward with internal stakeholders and external partnersDiagnostic Affairs: Lead the international diagnosis approach to achieve rapid acceleration of genetic testing and diagnosis across priority markets and drive optimisation and standardisation of testing practicesStrategic Planning & Execution:Be a key contributor on global strategy; collaborating with team members on design, readiness and execution of key strategic projects with international impact

CEPTON is a strategy consulting boutique operating on a global scale. From strategy consulting to complex transactions, we focus on a limited number of industries facilitating a reliable and comprehensive service to develop your business. We provide innovative solutions to match these constantly evolving markets and can facilitate your expansion to new markets.Example of projects (not exhaustive): - Go to market strategies for SAXS technology, Medical oxygen generators, AI diagnostics, genetic testing and several rare disease biotechs- Strategic and Vendor Due Diligence projects for private equity firms (Pharma industry, medical devices,...)- Market segmentation & evaluation of strategic opportunities for several CROs and CDMOs, food supplement companies and mid-size Pharma companies- Strategic reorganisation & definition of new P&L for several Big Pharma- Evaluation of the European biosimilar market for a Big Pharma- Life-cycle management and Real-World Evidence strategy in the context of COVID-19 for a Big Pharma- Sales force effectiveness assessment- Definition of a product development governance framework

Mathematical Institute - Institute for New Economic Thinking - Complexity Economics ProgrammeINET Oxford is a rapidly expanding interdisciplinary research centre founded at the Oxford Martin School. Our team of top scholars from across the sciences, social sciences and humanities work together with policymakers and practitioners to develop innovative new approaches to major economic issues.My thesis studies a theory for the amplification of technological improvement by the production network structure of the economy.The theory is motivated by the idea that, to the extent that inputs and outputs of industries form a chain, improvements are passed down the chain and accumulate multiplicatively. Under a simple model for technological improvement it is possible to compute the overall improvement factor for the general case where the production network has a complicated structure containing cycles. We call this the trophic depth by analogy with ecology.

Confining collective motion

Thermal capillary waves in confinement

Stability of air bubble at the air-water interface